You are here

selatogrel

Viatris splashes out $350m on pair of Idorsia therapies

Pharmaphorum

Wed, 02/28/24 - 10:45 am

myocardial infarction

Idorsia's selatogrel hits goals in phase 2 cardiovascular trials

Fierce Biotech

Tue, 12/18/18 - 10:37 am

clinical trials

coronary artery disease

acute myocardial infarctions